Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453277) titled 'Blood-Based Molecular Clock Biomarkers Predict Acute Ischemic Stroke Onset: A... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453394) titled 'QLS5132 Combination Therapy in Advanced Solid Tumors' on March 1. Study Type... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452380) titled 'The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452783) titled 'Circadian Clock Gene Expression in Periodontal Disease' on March 1. Study Ty... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452874) titled 'Community-Based Occupational Therapy for Syrian Refugees to Improve Social Pa... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453355) titled 'EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA' on March 1. S... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453407) titled 'ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Ther... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452341) titled 'Effect of Virtual Reality on Depression in Adolescent Females' on March 1. S... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07452835) titled 'Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disor... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453368) titled 'Orelabrutinib in the Treatment of Relapsed/Refractory AIHA' on March 1. Stud... Read More